Matthew B. Klein sold $556K of PTC Therapeutics (PTCT)

Executed Aug 5 2025, disclosed Aug 5 2025, the same day.

Value, as filed

$556K

10,739 sh × $51.74

Executed

Aug 5 2025

the trade date, as filed

Disclosed

Aug 5 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Matthew B. Klein Director profile →

Matthew B. Klein (Director) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in PTC Therapeutics, Inc. (PTCT). The largest single filing was $868K of PTCT (11,893 sh across 3 lots, as filed), executed May 14.

The name

PTCT

PTC Therapeutics, Inc. PTCT · Healthcare · 80 filings in 24 months ticker →

Healthcare · PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Matthew B. Klein in PTCT

PTCTSALE PTC Therapeutics, Inc. $706K
10,292 sh × $68.57
Exec Aug 4
Filed Aug 6 · 5:20 PM ET PTCTSALE PTC Therapeutics, Inc. $868K
11,893 sh across 3 lots
Exec May 14
Filed May 15 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. $202K
2,850 sh × $70.91
Exec Apr 21
Filed Apr 23 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. $171K
2,662 sh × $64.08
Exec Mar 12
Filed Mar 13 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. $511K
7,371 sh × $69.36
Exec Feb 18
Filed Feb 20 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. $192K
2,514 sh × $76.45
Exec Jan 8
Filed Jan 12 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. $630K
8,165 sh across 2 lots
Exec Jan 6
Filed Jan 8 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. $620K
8,089 sh × $76.64
Exec Dec 30 2025
Filed Jan 2 · 5:30 PM ET